Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 134 (3) , 753-756
Abstract
No abstract availableFunding Information
- The Netherlands Organisation for Scientific Research
This publication has 14 references indexed in Scilit:
- Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic eventThrombosis Research, 2014
- Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with CirrhosisPLOS ONE, 2014
- Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveatsJournal of Hepatology, 2013
- Coagulation Proteins Influencing Global Coagulation Assays in Cirrhosis: Hypercoagulability in Cirrhosis Assessed by Thrombomodulin-Induced Thrombin Generation AssayBioMed Research International, 2013
- Anticoagulation in cirrhosis patients: What don't we know?Liver International, 2010
- Enhanced thrombin generation in patients with cirrhosis‐induced coagulopathyJournal of Thrombosis and Haemostasis, 2010
- Rebalanced hemostasis in patients with liver disease: evidence and clinical consequencesBlood, 2010
- Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation testsJournal of Hepatology, 2010
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡Hepatology, 2005
- Haemostatic abnormalities in patients with liver diseaseJournal of Hepatology, 2002